Cargando…

Integrin αvβ3 and CD44 pathways in metastatic prostate cancer cells support osteoclastogenesis via a Runx2/Smad 5/receptor activator of NF-κB ligand signaling axis

BACKGROUND: Bone loss and pathological fractures are common skeletal complications associated with androgen deprivation therapy and bone metastases in prostate cancer patients. We have previously demonstrated that prostate cancer cells secrete receptor activator of NF-kB ligand (RANKL), a protein es...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gupta, Aditi, Cao, Wei, Chellaiah, Meenakshi A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3499378/ https://www.ncbi.nlm.nih.gov/pubmed/22966907 http://dx.doi.org/10.1186/1476-4598-11-66

Ejemplares similares

Characterization of CD44 intracellular domain interaction with RUNX2 in PC3 human prostate cancer cells
por: Senbanjo, Linda T., et al.
Publicado: (2019)

Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells
por: Desai, Bhavik, et al.
Publicado: (2007)

C-phycocyanin attenuates RANKL-induced osteoclastogenesis and bone resorption in vitro through inhibiting ROS levels, NFATc1 and NF-κB activation
por: AlQranei, Mohammed S., et al.
Publicado: (2020)

Lipopolysaccharide- TLR-4 Axis regulates Osteoclastogenesis independent of RANKL/RANK signaling
por: AlQranei, Mohammed S., et al.
Publicado: (2021)

Identification of sequence-specific interactions of the CD44-intracellular domain with RUNX2 in the transcription of matrix metalloprotease-9 in human prostate cancer cells
por: Senbanjo, Linda T., et al.
Publicado: (2020)

NF-κB-Mediated Regulation of Osteoclastogenesis
por: Boyce, Brendan F., et al.
Publicado: (2015)

IL-35 inhibits human osteoclastogenesis from monocytes induced by receptor-activator of NF-κB ligand
por: Yago, Toru, et al.
Publicado: (2018)

Osteopontin and MMP9: Associations with VEGF Expression/Secretion and Angiogenesis in PC3 Prostate Cancer Cells
por: Gupta, Aditi, et al.
Publicado: (2013)

Oridonin Attenuates Thioacetamide-Induced Osteoclastogenesis Through MAPK/NF-κB Pathway and Thioacetamide-Inhibited Osteoblastogenesis Through BMP-2/RUNX2 Pathway
por: Jin, XiaoLi, et al.
Publicado: (2023)

CD44: A Multifunctional Cell Surface Adhesion Receptor Is a Regulator of Progression and Metastasis of Cancer Cells
por: Senbanjo, Linda T., et al.
Publicado: (2017)

Androgen receptor expression reduces stemness characteristics of prostate cancer cells (PC3) by repression of CD44 and SOX2
por: Srinivasan, Deepa, et al.
Publicado: (2018)

Membrane Localization of Membrane Type 1 Matrix Metalloproteinase by CD44 Regulates the Activation of Pro-Matrix Metalloproteinase 9 in Osteoclasts
por: Chellaiah, Meenakshi A., et al.
Publicado: (2013)

Isopsoralen suppresses receptor activator of nuclear factor kappa-β ligand-induced osteoclastogenesis by inhibiting the NF-κB signaling
por: Zhan, Wanda, et al.
Publicado: (2023)

Staphylococcus Aureus Induces Osteoclastogenesis via the NF-κB Signaling Pathway
por: Ren, Li-Rong, et al.
Publicado: (2017)

Cimifugin Suppresses NF-κB Signaling to Prevent Osteoclastogenesis and Periprosthetic Osteolysis
por: Duan, Juan, et al.
Publicado: (2021)

TAZ inhibits osteoclastogenesis by attenuating TAK1/NF-κB signaling
por: Yang, Wanlei, et al.
Publicado: (2021)

PARK2 Induces Osteoclastogenesis through Activation of the NF-κB Pathway
por: Hong, Seo Jin, et al.
Publicado: (2022)

The IκB Function of NF-κB2 p100 Controls Stimulated Osteoclastogenesis
por: Novack, Deborah Veis, et al.
Publicado: (2003)

Receptor activator of NF-κB ligand induces cell adhesion and integrin α2 expression via NF-κB in head and neck cancers
por: Yamada, Tamaki, et al.
Publicado: (2016)

Resveratrol-mediated SIRT-1 Interactions with p300 Modulate Receptor Activator of NF-κB Ligand (RANKL) Activation of NF-κB Signaling and Inhibit Osteoclastogenesis in Bone-derived Cells
por: Shakibaei, Mehdi, et al.
Publicado: (2011)

RUNX1: A Regulator of NF-κB Signaling in Pulmonary Diseases
por: Tang, Xiaoju, et al.
Publicado: (2018)

Calycosin Suppresses RANKL-Mediated Osteoclastogenesis through Inhibition of MAPKs and NF-κB
por: Quan, Gui-Hua, et al.
Publicado: (2015)

Strontium Ranelate Inhibits Osteoclastogenesis through NF-κB-Pathway-Dependent Autophagy
por: Wu, Dongle, et al.
Publicado: (2023)

Promising Noninvasive Cellular Phenotype in Prostate Cancer Cells Knockdown of Matrix Metalloproteinase 9
por: Gupta, Aditi, et al.
Publicado: (2013)

CD44 regulates bone erosion and osteoclastogenesis in arthritis
por: Schett, G, et al.
Publicado: (2003)

CD44 regulates bone erosion and osteoclastogenesis in arthritis
por: Hayer, S, et al.
Publicado: (2004)

Smad4 is required to inhibit osteoclastogenesis and maintain bone mass
por: Morita, Mayu, et al.
Publicado: (2016)

Staphylococcus aureus Protein A induces osteoclastogenesis via the NF-κB signaling pathway
por: Ren, Li-Rong, et al.
Publicado: (2017)

TNF-α and RANKL promote osteoclastogenesis by upregulating RANK via the NF-κB pathway
por: Luo, Gang, et al.
Publicado: (2018)

Lithium chloride inhibits titanium particle-induced osteoclastogenesis by inhibiting the NF-κB pathway
por: Hu, Xuanyang, et al.
Publicado: (2017)

Schistosoma japonicum cystatin suppresses osteoclastogenesis via manipulating the NF-κB signaling pathway
por: Chen, Yu, et al.
Publicado: (2021)

Juglanin Inhibits Osteoclastogenesis in Ovariectomized Mice via the Suppression of NF-κB Signaling Pathways
por: Zhang, Fangxue, et al.
Publicado: (2021)

Role of Runx2 Phosphorylation in Prostate Cancer and Association with Metastatic Disease
por: Ge, Chunxi, et al.
Publicado: (2015)

Methylsulfonylmethane Inhibits RANKL-Induced Osteoclastogenesis in BMMs by Suppressing NF-κB and STAT3 Activities
por: Joung, Youn Hee, et al.
Publicado: (2016)

Protective Effects of Punicalagin on Osteoporosis by Inhibiting Osteoclastogenesis and Inflammation via the NF-κB and MAPK Pathways
por: Wang, Wei, et al.
Publicado: (2020)

Galangin suppresses RANKL‐induced osteoclastogenesis via inhibiting MAPK and NF‐κB signalling pathways
por: Li, Xiucheng, et al.
Publicado: (2021)

Carnosol inhibits osteoclastogenesis in vivo and in vitro by blocking the RANKL-induced NF-κB signaling pathway
por: Cai, Pan, et al.
Publicado: (2022)

RUNX1/CD44 axis regulates the proliferation, migration, and immunotherapy of gliomas: A single-cell sequencing analysis
por: Zhang, Hao, et al.
Publicado: (2023)

Perillaldehyde inhibits bone metastasis and receptor activator of nuclear factor-κB ligand (RANKL) signaling-induced osteoclastogenesis in prostate cancer cell lines
por: Lin, Zhuoyuan, et al.
Publicado: (2022)

Osteoactivin inhibition of osteoclastogenesis is mediated through CD44-ERK signaling
por: Sondag, Gregory R, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_qhiuqg03tmop9nuvecu67gj48l